Related references
Note: Only part of the references are listed.Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial
James A. Allay et al.
HUMAN GENE THERAPY (2011)
Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins
Amit C. Nathwani et al.
MOLECULAR THERAPY (2011)
Characterization of a Recombinant Adeno-Associated Virus Type 2 Reference Standard Material
Martin Lock et al.
HUMAN GENE THERAPY (2010)
Surfactant-induced amorphous aggregation of tobacco mosaic virus coat protein: A physical methods approach
Yuliy V. Panyukov et al.
MACROMOLECULAR BIOSCIENCE (2008)
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo
Z Wang et al.
GENE THERAPY (2003)
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo
DM McCarty et al.
GENE THERAPY (2003)
Quantification of adeno-associated virus particles and empty capsids by optical density measurement
JM Sommer et al.
MOLECULAR THERAPY (2003)
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis
DM McCarty et al.
GENE THERAPY (2001)
Share Paper
